Lithium hydroxide, monohydrate → 2-(5-allyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetic acid
Reaction equation
[CH2:1]([C:4]1[N:8]([CH2:9][C:10]([O:12]C)=[O:11])[N:7]=[C:6]([C:14]([F:17])([F:16])[F:15])[CH:5]=1)[CH:2]=[CH2:3].O.[OH-].[Li+]>C1COCC1.O.CO>[CH2:1]([C:4]1[N:8]([CH2:9][C:10]([OH:12])=[O:11])[N:7]=[C:6]([C:14]([F:16])([F:17])[F:15])[CH:5]=1)[CH:2]=[CH2:3]Participants
6
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Procedure
Methyl 2-(5-allyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate (120 mg, 0.48 mmol) was dissolved in THF (1 mL). To this solution was added lithium hydroxide monohydrate (70 mg) in water (1 mL) and MeOH (0.1 mL). The resulting solution was stirred at room temperature overnight. Upon completion of the reaction, the product was purified by reverse phase HPLC eluting with acetonitrile/water (with 0.1% TFA) to afford 2-(5-allyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetic acid (110 mg, 99%) as an oil. MS (m/z): 235.3 [M+H]+; HPLC retention time 3.03 min (2-98% acetonitrile:water with 0.05% trifluoroacetic acid).
Workup
- customUpon completion of the reaction
- customthe product was purified by reverse phase HPLC
- washeluting with acetonitrile/water (with 0.1% TFA)
Sources & evidence
- ORD record
- ord-d0213fa3bafd4ca196dfe611fb4bf4c4
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09012441B2
Reaction notes
Loading…